Quantcast Medical Firms Make Product Placement Deals With Er, Grey's Anatomy
Search by tag or site Login to my blog ? Start my own blog














TheMoneyBlogs
Home
About
Create your own blog
Contact us
Vote for this blog!

BioHealth Investor

BioHealth Investor (BHI) is a blog and journal focused on providing updated commentary and financial news from the biotech and medical technology industry. BHI's content is featured on Yahoo!Finance, Google Finance, TheStreet.com, SeekingAlpha.com and many other blogs and websites. BHI is also a proud member of The Business of Biotech Network, and the Investors Blog Network.

Medical Firms Make Product Placement Deals With Er, Grey's Anatomy

Posted on 05/01/2007 08:17:29 | Link | Post Comment
by Sara Calabro
Med Tech Sentinel



Small medical device firms don’t spend much time worrying about advertising. When working within tight budget constraints, a 30-second spot is a luxury most emerging firms can’t afford. But product placement may be an opportunity for smaller companies to get their products in front of a consumer audience – without breaking the bank.

Washington CEO magazine today has an article about three Seattle-area firms that have landed their products on Grey’s Anatomy and ER through barter deals with television networks. Philips Medical Systems, Cardiac Science (CSCX) and SonoSite (SONO) have seen their devices appear on one or both shows and have paid nothing for the honor. “These relationships are basically win-win because these productions need the props, and this helps us to build awareness of our brand,” Philips’s North American CEO Brent Shafer tells Washington CEO. He says it would cost between $7 million and $8 million to buy the equivalent amount of air time to what Philips gets for free each year through product placement barter deals.

Sure, established companies like Philips have the manpower to negotiate these kinds of deals. But it’s something for small companies to consider. Instead of saving pennies for that 30-second spot, perhaps a nominal investment in reallocating marketing resources to focus on barter deals would be a worthwhile investment.

“The fact is,” Cardiac Science’s VP of marketing, Garry Norris, tells CEO, “when our products appear in the show, we get a lot of e-mail. Customer service gets calls from people saying, ‘I saw your product on Grey’s Anatomy and wanted to learn more about it.’”


Source: OneMedPlace.com

_____________________
Stock Quote or
Examples
Morpheus Trading - Tue Sep 02, 2008 05:21AM
NOTE: Please click on the charts below to enlarge them [read more]
Morpheus Trading - Thu Sep 04, 2008 04:34AM
NOTE: Please click on the charts below to enlarge them if [read more]
Morpheus Trading - Wed Sep 03, 2008 04:35AM
NOTE: Please click on the charts below to enlarge them [read more]

PREMIER SPONSORED LINKS

Most Visited Blogs | Most Popular Blogs | Most Recent Blogs | Contact Us | Terms and conditions | Privacy Policy

The columns, articles, message board posts and any other features provided on TheMoneyBlogs.com are provided for personal finance, education and investment information and are not to be construed as investment advice. Under no circumstances does the information in this content represent a recommendation to buy, sell or hold any security. The views and opinions expressed in an article or column are the author's own and not necessarily those of TheMoneyBlogs.com and there is no implied endorsement by TheMoneyBlogs.com of any advice or trading strategy. The analysts and employees or affiliates of TheMoneyBlogs.com may hold positions in the stocks or industries discussed here. Your use of this and all information contained on TheMoneyBlogs.com is governed by the Terms and Conditions of Use. Please click the link to view those terms. Follow this link to read our Editorial Policy.

Copyright © 2008 The Connors Group, Inc.